- Regulations in Japan, the United States, and Europe, pre-market approval systems, healthcare insurance systems, and points to consider when entering new fields.
★Information packed that you can only hear here ★Part 1 → External factors that have a significant impact on the in vitro diagnostic (IVD) product market ("Regulatory frameworks in Japan, the U.S., and Europe (pre-market approval systems)" and "Healthcare systems in Japan, the U.S., and Europe (healthcare policies)") ★Part 2 → Explanation of the characteristics of the IVD market in various countries based on data Examples of marketing strategies for IVD products using infectious diseases and cancer diagnostics ★Discussion on emerging markets, LDTs, and hospital-acquired infection markets!? 【Speaker】 Kuwanai Technical Research Office (Kuwanai Research) Representative, Ph.D. in Agriculture, Kenji Kuwanai 【Venue】 Scheduled to be held in Chuo-ku, Tokyo 【Date and Time】August 7, 2014 (Thursday) 13:30-16:30
Inquire About This Product
basic information
【Lecture Summary】 In the first part, we will explain external factors that significantly impact the in vitro diagnostic (IVD) product market, specifically "regulatory frameworks in Japan, the United States, and Europe (pre-market approval systems)" and "healthcare insurance systems in Japan, the United States, and Europe (healthcare policies)." In the second part, we will discuss the characteristics of each country's IVD market based on data, and then, using examples from infectious diseases and cancer diagnostics, we will explain practical marketing strategies for IVD products. Additionally, we will provide insights into emerging markets, laboratory-developed tests (LDTs), and hospital-acquired infection markets, and finally, using infectious disease genetic testing as an example, we will outline key considerations for marketing strategies when entering new fields. 【Keywords】 1. Clinical testing 2. Marketing 3. U.S. market
Price information
Applications received by July 24th will be 43,200 yen (including tax and text costs) for 2 people from 1 company.
Price range
P2
Delivery Time
P2
Applications/Examples of results
Part 1: External Factors Surrounding the In Vitro Diagnostic Products (Devices and Reagents) Market 1. Regulatory Barriers and Reimbursement Barriers 1-1. Legal Regulations: GHTF Concepts 1-2. Medical Insurance Policies: Reimbursement System 1-3. Movements for Legal Revisions 2. Japan's Pre-Market Approval System 3. U.S. Pre-Market Approval System 4. European Pre-Market Approval System 5. Japan's Insurance Reimbursement System 6. U.S. Insurance Reimbursement System 7. European Insurance Reimbursement System (UK, Germany, France) Part 2: Marketing Strategies 8. Characteristics of the IVD Market in Japan, the U.S., and Europe 9. "Market Growth Process" and "Marketing Strategies" 10. Testing Market for Hospital-Acquired Infection Control (HAI: Hospital-acquired Infection; Healthcare-Associated Infection) 11. Considerations When Entering New Fields (Using Infectious Disease Genetic Testing as an Example) 12. Conclusion [Q&A and Business Card Exchange]
Company information
Our company has developed its business from "seminar planning" to various forms such as "lecturer dispatch," "publishing planning," "technical consultant dispatch," "trend research," "business matching," and "business development consulting," in order to support clients in a wide range of fields including chemistry, electronics, automotive, energy, medical devices, food, and building materials. By doing so, we have advanced our company and opened up new markets. AndTech promises to continue listening to our clients' voices, entering the business areas and markets they desire, and to remain a company that is loved by our clients, as we share their challenges, think together, and forge new paths.
![Basic Seminar for Obtaining the China CCC Mark [December 20, Tokyo]](https://image.mono.ipros.com/public/product/image/bf6/2000122724/IPROS8595059909811374036.png?w=280&h=280)
